Search all bills

Keyword(s)
Status
Current Bills
Previous Bills
Type

TOTAL RESULTS: 206

  • Date
    24 Mar 2021 
    Chamber
    House of Representatives 
    Status
    Before House of Representatives 
    Portfolio
    Health 
    Summary
    Amends the:
    Prohibition of Human Cloning for Reproduction Act 2002
    ,
    Research Involving Human Embryos Act 2002
    and
    Research Involving Human Embryos Regulations 2017
    to allow for the use of permitted mitochondrial donation techniques under a specified mitochondrial donation licence for the purposes of certain research and training, and in clinical settings; and
    Freedom of Information Act 1982
    ,
    Prohibition of Human Cloning for Reproduction Act 2002
    ,
    Research Involving Human Embryos Act 2002
    ,
    Research Involving Human Embryos Regulations 2017
    and
    Therapeutic Goods (Excluded Goods) Determination 2018
    to make consequential and technical amendments. 

    Bill | Explanatory Memorandum

  • Date
    13 Feb 2019 
    Chamber
    Senate 
    Status
    Before Senate 
    Sponsor
    HANSON-YOUNG, Sen Sarah 
    Summary
    Establishes a commission of inquiry, with the same powers as a royal commission, to inquire into the management of the Murray-Darling Basin water resources and related matters. 

    Bill | Explanatory Memorandum

  • Date
    27 Aug 2020 
    Chamber
    House of Representatives 
    Status
    Before Senate 
    Portfolio
    Attorney-General 
    Summary
    Introduced with the National Commissioner for Defence and Veteran Suicide Prevention Bill 2020, the bill amends the:
    Freedom of Information Act 1982
    to exclude the National Commissioner for Defence and Veteran Suicide, and the Attorney-General's Department to the extent they hold documents related to the performance and exercise of functions or powers of the Commissioner, from the application of the Act; and
    Inspector-General of Intelligence and Security Act 1986
    to allow the commissioner to be prescribed under the regulations to enable the Inspector-General of Intelligence and Security to voluntarily disclose information to the commissioner. 

    Bill | Explanatory Memorandum

  • Date
    27 Aug 2020 
    Chamber
    House of Representatives 
    Status
    Before Senate 
    Portfolio
    Attorney-General 
    Summary
    Introduced with the National Commissioner for Defence and Veteran Suicide Prevention (Consequential Amendments) Bill 2020, the bill establishes the National Commissioner for Defence and Veterans Suicide Prevention, as an independent statutory office holder, to examine defence and veteran deaths by suicide through a broad range of functions and powers, in order to support the prevention of future deaths by suicide. 

    Bill | Explanatory Memorandum

  • Date
    02 Dec 2019 
    Chamber
    Senate 
    Status
    Before Senate 
    Sponsor
    GRIFF, Sen Stirling
    MCALLISTER, Sen Jenny 
    Summary
    Amends the
    National Consumer Credit Protection Act 2009
    to: impose a cap on the total payments that can be made under a consumer lease (known as rent-to-buy schemes); require small amount credit contracts (SACCs) (known as payday loans) to have equal repayment and payment intervals; remove the ability for SACC providers to charge monthly fees in respect of the residual term of a loan where a consumer fully repays the loan early; prevent lessors and credit assistance providers from undertaking door-to-door selling of leases at residential homes; introduce anti-avoidance protections; and increase penalties. 

    Bill | Explanatory Memorandum

  • Date
    09 Dec 2020 
    Chamber
    House of Representatives 
    Status
    Before Senate 
    Portfolio
    Treasury 
    Summary
    Amends the:
    National Consumer Credit Protection Act 2009
    to: provide that responsible lending obligations apply only to small amount credit contracts, small amount credit contract-equivalent loans provided by authorised deposit-taking institutions (ADIs) and consumer leases; provide the minister with the power to determine standards specifying requirements for a credit licensee's systems, policies and processes in relation to certain non-ADI credit conduct; impose a cap on the total payments that can be made by a lessee in connection with a consumer lease; extend the protected earnings requirement for small amount credit contracts to cover all consumers and introduce a similar protected earnings requirements for consumer leases for household goods; restrict the use and disclosure of account statements; amend requirements for licensees to disclose information to consumers; introduce broad anti-avoidance protections to prohibit schemes that are designed to avoid the application of the Act in relation to small amount credit contracts and consumer leases; and make consequential amendments; and
    Age Discrimination Act 2004
    to exempt the reverse mortgage scheme from the application of the Act. 

    Bill | Explanatory Memorandum

  • Date
    03 Jun 2021 
    Chamber
    House of Representatives 
    Status
    Assent 
    Portfolio
    National Disability Insurance Scheme 
    Summary
    Implements certain recommendations of the
    Independent review of the adequacy of the regulation of the supports and services provided to Ms Ann-Marie Smith, an NDIS participant, who died on 6 April 2020
    by amending the
    National Disability Insurance Scheme Act 2013
    to: expand the compliance and enforcement powers of the Commissioner of the NDIS Quality and Safeguards Commission; clarify provider registration provisions; and enable information sharing between the National Disability Insurance Agency and the commission and the disclosure of information to relevant state and territory bodies. 

    Bill | Explanatory Memorandum

  • Date
    28 Oct 2021 
    Chamber
    House of Representatives 
    Status
    Before House of Representatives 
    Portfolio
    National Disability Insurance Scheme 
    Summary
    Implements certain recommendations of the 2019 review of the
    National Disability Insurance Scheme Act 2013
    (the Tune review) by amending the: National Disability Insurance Scheme Act 2013 to establish the Participant Service Guarantee to provide timeframes and engagement principles for how the National Disability Insurance Agency undertakes key administrative processes; enable participant’s plans to be varied without requiring a full plan review; amend the objects and principles of the Act; clarify the eligibility criteria for people with psychosocial disability; streamline certain administrative processes for participants; provide clarity in relation to decisions about plan management requests and extend the risk assessment process for self-management of funding to those using registered plan management providers; enable the National Disability Insurance Agency to make direct payments on behalf of participants; and remove redundant provisions and make technical amendments; and
    DisabilityCare Australia Fund Act 2013
    to make a consequential amendment. 

    Bill | Explanatory Memorandum

  • Date
    28 Oct 2021 
    Chamber
    House of Representatives 
    Status
    Before House of Representatives 
    Portfolio
    Health 
    Summary
    Amends the:
    National Health Act 1953
    to: provide for price reductions on the fifth, tenth and fifteenth anniversary of a drug listing on the Pharmaceutical Benefits Scheme (PBS), and when the first new brand of a drug lists on the PBS; retain ministerial discretion to ensure that the minister can intervene if a legislated price reduction were to have an unintended consequence; and establish a price reduction floor, and stockholding requirements, for certain PBS listed brands that may be susceptible to global medicines shortages; and
    National Health Amendment (Pharmaceutical Benefits—Budget and Other Measures) Act 2018
    to remove redundant provisions. 

    Bill | Explanatory Memorandum

  • Date
    17 Mar 2021 
    Chamber
    Senate 
    Status
    Before Senate 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to: establish the statutory authority for the publication of information in relation to the Pharmaceutical Benefits Advisory Committee, including meeting agendas, meeting outcomes, public summary documents and information published on the Medicine Status Website; and provide for cost recovery arrangements, including specifying fees for services and costs incurred to be set out in a disallowable legislative instrument, replacing the existing regulations; and make consequential amendments. 

    Bill | Explanatory Memorandum

Browse bills

Browse all bills by title
Latest updates to bill homepages
Bills lists

These publications provide a complete list of all bills before Parliament for the current calendar year and details of their progress through both houses of Parliament.

More on bills

Bills and committees

The House of Representatives Selection Committee and the Senate Selection of Bills Committee routinely consider whether bills should be referred to committees for inquiry and report. The House Committee reports its determinations to the chamber, while the Senate Committee makes recommendations which the Senate may then adopt. Bills may also be referred to committees by either chamber or by the relevant minister to House and joint committees.

Acts and Australian Law
Legislation proposed for introduction (external links)
Senate statistics